Can we talk? We’re all friends here, right? Safe zone and all?Man, I just had a DAY in the clinic. My first five patients all had dry eye syndrome (DES), all were dramatically better than when they started, and nobody was happy. You take care of DES patients so you know what I mean. There’s no question that all of the developments that we’ve seen have made it easier to take care of DES and other forms of ocular surface disease than any time in history. The reason more people (Read more...)
Poor anti-VEGF response may be linked to obstructive sleep apnea in patients with AMD, DME
Patients with exudative age-related macular degeneration or diabetic macular edema who responded poorly to anti-VEGF therapy may have an elevated risk of obstructive sleep apnea, according to a study.The case-control study included 103 patients diagnos…
Visual acuity remains unchanged after switch to aflibercept treatment
A switch to aflibercept treatment in patients with neovascular age-related macular degeneration resulted in a significant decrease in the number of injections, central retinal thickness and retinal pigment epithelial detachment volume, but visual acuit…
OSN round table, part 2: How to become a better femtosecond laser cataract surgeon
At the European Society of Cataract and Refractive Surgeons meeting, Ocular Surgery News gathered an international panel of experts to discuss their experiences with femtosecond laser-assisted cataract surgery, with the objective of improving the proce…
Rituximab May Be Helpful in Graves’ Orbitopathy
Compared to IV methylprednisolone for Graves’ orbitopathy, rituximab offers a number of advantages, Italian researchers say. Reuters Health Information
Ten most-read ophthalmology news stories of the year
From notable breaking news stories to groundbreaking studies presented at annual ophthalmology meetings, 2014 has proved to be an innovative year for ophthalmology, with much more surgical and technological advancement to look forward to in 2015. The m…